| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8242190 | International Journal of Radiation Oncology*Biology*Physics | 2007 | 7 Pages |
Abstract
Conclusions: Trials of more aggressive and innovative locoregional and systemic therapies are warranted in high-risk patients, based on their T and N stages. The majority of locoregional failures involve the anus and rectum, whereas inguinal recurrences occur rarely. Placing the superior border of the radiotherapy field at L5/S1 could potentially reduce pelvic recurrences.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Prajnan M.D., M.S., M.P.H., Sumita M.D., Cathy M.D., Jaffer A. M.D., John M. M.D., Miguel A. M.D., George J. M.D., Priya M.D., Marc E. M.D., Sunil M.D., Nora A. M.D., M.P.S.A., Christopher H. M.D.,